Pantoprazol Stada (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazol Stada, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Stada is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): Improves the healing of the esophageal lining and relieves heartburn and acid reflux symptoms. - Erosive oesophageal disease: Provides the primary healing of erosions and ulcers in the oesophagus. - Peptic ulcer disease (duoden‑ and gastric ulcers): Promotes ulcer healing and prevents recurrence by suppress the acid output . - Zoll‑‑   ---